Graham Dixon, PhD

Graham Dixon has a twenty year track record in research and development in pharmaceutical industry, particularly oncology, having held senior management positions within big pharma and biotech. Graham Dixon is currently Chief Scientific Officer/Head R&D for Onxeo, a publically listed biotech specialized in orphan oncology indications.  For nearly ten years, Graham worked as Director of R&D with the European biotech Galapagos, accompanying its growth and international development. Graham Dixon holds a PhD in Biochemistry from the University of Swansea, Wales and an honors degree in Biology from the University of Bradford. He has numerous patents and scientific publications.

Back to scientific advisory board